273 related articles for article (PubMed ID: 28550425)
1. CpG oligonucleotide-mediated co-stimulation of mouse invariant natural killer T cells negatively regulates their activation status.
Kulkarni RR; Villanueva AI; Read LR; Brisbin JT; Bhaumik SK; LaMarre J; Murali-Krishna K; Sharif S
Cell Tissue Res; 2017 Sep; 369(3):541-554. PubMed ID: 28550425
[TBL] [Abstract][Full Text] [Related]
2. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.
Stuart JK; Bisch SP; Leon-Ponte M; Hayatsu J; Mazzuca DM; Maleki Vareki S; Haeryfar SM
Int Immunopharmacol; 2010 Sep; 10(9):1068-76. PubMed ID: 20584631
[TBL] [Abstract][Full Text] [Related]
3. Costimulatory activation of murine invariant natural killer T cells by toll-like receptor agonists.
Kulkarni RR; Villanueva AI; Elawadli I; Jayanth P; Read LR; Haeryfar SM; Sharif S
Cell Immunol; 2012; 277(1-2):33-43. PubMed ID: 22795895
[TBL] [Abstract][Full Text] [Related]
4. Dissociated expression of natural killer 1.1 and T-cell receptor by invariant natural killer T cells after interleukin-12 receptor and T-cell receptor signalling.
Emoto M; Shimizu T; Koike H; Yoshizawa I; Hurwitz R; Kaufmann SH; Emoto Y
Immunology; 2010 Jan; 129(1):62-74. PubMed ID: 20028429
[TBL] [Abstract][Full Text] [Related]
5. Role of marginal zone B lymphocytes in invariant NKT cell activation.
Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
[TBL] [Abstract][Full Text] [Related]
6. Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation.
Iyoda T; Ushida M; Kimura Y; Minamino K; Hayuka A; Yokohata S; Ehara H; Inaba K
Int Immunol; 2010 Nov; 22(11):905-13. PubMed ID: 21118907
[TBL] [Abstract][Full Text] [Related]
7. Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control.
Guan P; Schaub R; Nichols KE; Das R
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708464
[TBL] [Abstract][Full Text] [Related]
8. Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model.
Rosalia RA; Štěpánek I; Polláková V; Šímová J; Bieblová J; Indrová M; Moravcová S; Přibylová H; Bontkes HJ; Bubeník J; Sparwasser T; Reiniš M
Immunobiology; 2013 Jun; 218(6):851-9. PubMed ID: 23182710
[TBL] [Abstract][Full Text] [Related]
9. Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses.
Grajewski RS; Hansen AM; Agarwal RK; Kronenberg M; Sidobre S; Su SB; Silver PB; Tsuji M; Franck RW; Lawton AP; Chan CC; Caspi RR
J Immunol; 2008 Oct; 181(7):4791-7. PubMed ID: 18802082
[TBL] [Abstract][Full Text] [Related]
10. Activation of decidual invariant natural killer T cells promotes lipopolysaccharide-induced preterm birth.
Li L; Yang J; Jiang Y; Tu J; Schust DJ
Mol Hum Reprod; 2015 Apr; 21(4):369-81. PubMed ID: 25589517
[TBL] [Abstract][Full Text] [Related]
11. Sodium chloride inhibits IFN-γ, but not IL-4, production by invariant NKT cells.
Jeong D; Kim HY; Chung DH
J Leukoc Biol; 2018 Jan; 103(1):99-106. PubMed ID: 29345057
[TBL] [Abstract][Full Text] [Related]
12. Activation of iNKT Cells Facilitates Liver Repair After Hepatic Ischemia Reperfusion Injury Through Acceleration of Macrophage Polarization.
Goto T; Ito Y; Satoh M; Nakamoto S; Nishizawa N; Hosono K; Naitoh T; Eshima K; Iwabuchi K; Hiki N; Amano H
Front Immunol; 2021; 12():754106. PubMed ID: 34691073
[TBL] [Abstract][Full Text] [Related]
13. The Invariant NKT Cell Response Has Differential Signaling Requirements during Antigen-Dependent and Antigen-Independent Activation.
Anderson CK; Reilly SP; Brossay L
J Immunol; 2021 Jan; 206(1):132-140. PubMed ID: 33229442
[TBL] [Abstract][Full Text] [Related]
14. T cell Ig domain and mucin domain 1 engagement on invariant NKT cells in the presence of TCR stimulation enhances IL-4 production but inhibits IFN-gamma production.
Kim HS; Kim HS; Lee CW; Chung DH
J Immunol; 2010 Apr; 184(8):4095-106. PubMed ID: 20220086
[TBL] [Abstract][Full Text] [Related]
15. Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice.
Homma T; Kinugawa S; Takahashi M; Sobirin MA; Saito A; Fukushima A; Suga T; Takada S; Kadoguchi T; Masaki Y; Furihata T; Taniguchi M; Nakayama T; Ishimori N; Iwabuchi K; Tsutsui H
J Mol Cell Cardiol; 2013 Sep; 62():179-88. PubMed ID: 23774048
[TBL] [Abstract][Full Text] [Related]
16. Differential indirect activation of human invariant natural killer T cells by Toll-like receptor agonists.
Moreno M; Mol BM; von Mensdorff-Pouilly S; Verheijen RH; de Jong EC; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
Immunotherapy; 2009 Jul; 1(4):557-70. PubMed ID: 20635987
[TBL] [Abstract][Full Text] [Related]
17. Human invariant natural killer T cells acquire transient innate responsiveness via histone H4 acetylation induced by weak TCR stimulation.
Wang X; Bishop KA; Hegde S; Rodenkirch LA; Pike JW; Gumperz JE
J Exp Med; 2012 May; 209(5):987-1000. PubMed ID: 22508835
[TBL] [Abstract][Full Text] [Related]
18. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
[TBL] [Abstract][Full Text] [Related]
19. Co-operation of α-galactosylceramide-loaded tumour cells and TLR9 agonists induce potent anti-tumour responses in a murine colon cancer model.
Dong T; Yi T; Yang M; Lin S; Li W; Xu X; Hu J; Jia L; Hong X; Niu W
Biochem J; 2016 Jan; 473(1):7-19. PubMed ID: 26450924
[TBL] [Abstract][Full Text] [Related]
20. Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop.
Exley MA; Hou R; Shaulov A; Tonti E; Dellabona P; Casorati G; Akbari O; Akman HO; Greenfield EA; Gumperz JE; Boyson JE; Balk SP; Wilson SB
Eur J Immunol; 2008 Jun; 38(6):1756-66. PubMed ID: 18493987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]